Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma

Background: Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (PLOD2), a key enzyme that catalyzes the hydroxylation of lysine, plays a crucial role in the progression of several solid tumors. However, its spatial expression profile and prognostic significance in oral squamous cell carcinoma (OSCC)...

Full description

Bibliographic Details
Main Authors: Yawei Sun, Shuai Wang, Xingwei Zhang, Zhuhao Wu, Zihui Li, Zhuang Ding, Xiaofeng Huang, Sheng Chen, Yue Jing, Xiaoxin Zhang, Liang Ding, Yuxian Song, Guowen Sun, Yanhong Ni
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Biomolecules
Subjects:
PLOD2
oral squamous cell carcinoma
prognosis
metabolomics
epithelial–mesenchymal transformation
Online Access:https://www.mdpi.com/2218-273X/11/12/1842

Internet

https://www.mdpi.com/2218-273X/11/12/1842

Similar Items